BMRN Earnings

BMRN reported its earnings on 2026-05-04, showcasing a revenue of 766.21M against an estimate of 766.26M, resulting in a -0.01% surprise. The EPS was 0.76, surpassing the expected 0.89 by -14.61%. The stock experienced a -4% price change on the earnings day and a -2.52% change over the next five days, reflecting market reactions to the results.

Following BMRN's earnings announcement on 2026-05-04, the stock price moved by -4% on the day of the release. Over the subsequent five days, it saw a -2.52% change. Historically, BMRN's stock price tends to shift by an average of -2.03% in the 10 days leading up to earnings and -1.67% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate BMRN's annual revenue to reach 869.76M, while the EPS is projected at 0.92. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between BMRN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, BMRN's stock price typically moves by -2.03% in the 10 days before its earnings and -1.67% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 0.92 and revenue of 869.76M.

BioMarin reported strong financial performance with a 12% revenue increase and a 20% rise in net income, driven by successful product sales. Operating margin improved, indicating operational efficiency. However, regulatory and competitive risks were noted, but these are common in the industry. The absence of clear negative guidance or significant concerns in the Q&A suggests a positive outlook. Despite the lack of market cap data, the financial results and operational improvements are likely to lead to a positive stock price movement in the short term.